RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of COGT
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Cogent Biosciences, Inc. stock price on Tuesday which ended trading at $8.24
(Updated on Jul 02, 2024)

Sell candidate since Jul 02, 2024 PDF

The Cogent Biosciences, Inc. stock price fell by -7.83% on the last day (Tuesday, 2nd Jul 2024) from $8.94 to $8.24. During the last trading day the stock fluctuated 12.02% from a day low at $8.07 to a day high of $9.04. The price has fallen in 6 of the last 10 days and is down by -6.36% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -98 thousand shares and in total, 817 thousand shares were bought and sold for approximately $6.73 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.76% during the next 3 months and, with a 90% probability hold a price between $10.79 and $13.10 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

COGT Signals & Forecast

There are few to no technical positive signals at the moment. The Cogent Biosciences, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $8.48 and $8.25. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 12, 2024, and so far it has fallen -8.85%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Cogent Biosciences, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $7.29 and $6.71. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cogent Biosciences, Inc. finds support just below today's level at $7.29. If this is broken, then the next support from accumulated volume will be at $6.71 and $6.50.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.97 between high and low, or 12.02%. For the last week, the stock has had daily average volatility of 8.76%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (COGT) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Cogent Biosciences, Inc. to open at $8.45, and during the day (based on 14 day Average True Range), to move between $7.59 and $8.89, which gives a possible trading interval of +/-$0.653 (+/-7.92%) up or down from last closing price. If Cogent Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 15.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.43 (2.31%) than the support at $7.29 (11.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cogent Biosciences, Inc. stock A Buy?

The Cogent Biosciences, Inc. stock holds several negative signals and despite the positive trend, we believe Cogent Biosciences, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

Current score: -5.170 Strong Sell Candidate Downgraded

Predicted Opening Price for Cogent Biosciences, Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$8.45 ( 2.55%) $8.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for COGT

Fibonacci Support & Resistance Levels

Level Price
R3 9.42 14.32%
R2 9.05 9.82%
R1 8.82 7.05%
Price 8.24
S1 8.08 -1.95%
S2 7.85 -4.73%
S3 7.48 -9.22%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.80 6.80%
R2 8.79 6.67%
R1 8.43 2.31%
Price 8.24
S1 7.29 -11.53%
S2 6.71 -18.57%
S3 6.50 -21.12%

FAQ

What is the symbol for Cogent Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Cogent Biosciences, Inc. is COGT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cogent Biosciences, Inc. Stock?
The Cogent Biosciences, Inc. stock holds several negative signals and despite the positive trend, we believe Cogent Biosciences, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Sell candidate.

How to buy Cogent Biosciences, Inc. Stock?
Cogent Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cogent Biosciences, Inc. Stock.

What's the current price of Cogent Biosciences, Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an Cogent Biosciences, Inc. (COGT) share was $8.24.

What is the 52-week high and low for Cogent Biosciences, Inc. Stock?
The 52-week high for Cogent Biosciences, Inc. Stock is $13.36 and the 52-week low is $3.67.

What is the market capitalization of Cogent Biosciences, Inc. Stock?
As of the Jul 02, 2024, the market capitalization of Cogent Biosciences, Inc. is 854.784M.

When is the next earnings date for Cogent Biosciences, Inc.?
The upcoming earnings date for Cogent Biosciences, Inc. is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Cogent Biosciences, Inc.

Cogent Biosciences. Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon ... COGT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT